Sales forecast of major cannabis pharmaceutical products by world region 2023-2027
As of June 2023, it was forecasted that in 2027 global sales for the leading three pharmaceutical cannabis products will stand at around 1.4 billion U.S. dollars, of which over 883 million dollars will be generated in the United States. The three major products are Epidiolex, Dronabinol, and Sativex. This statistic illustrates the estimated sales forecast of major cannabis pharmaceutical products worldwide by region from 2023 to 2027.